Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

WST West Pharmaceutical Services Inc

Price (delayed)

$216.64

Market cap

$15.56B

P/E Ratio

33.74

Dividend/share

$0.83

EPS

$6.42

Enterprise value

$15.46B

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, ...

Highlights
The stock's price to earnings (P/E) is 29% less than its 5-year quarterly average of 47.3 and 22% less than its last 4 quarters average of 43.5
West Pharmaceutical Services's quick ratio has decreased by 4.3% from the previous quarter but it has increased by 3.4% YoY
The net income has contracted by 18% YoY and by 5% from the previous quarter
WST's EPS is down by 16% year-on-year and by 4.9% since the previous quarter

Key stats

What are the main financial stats of WST
Market
Shares outstanding
71.85M
Market cap
$15.56B
Enterprise value
$15.46B
Valuations
Price to earnings (P/E)
33.74
Price to book (P/B)
5.84
Price to sales (P/S)
5.42
EV/EBIT
26.47
EV/EBITDA
20.78
EV/Sales
5.34
Earnings
Revenue
$2.9B
Gross profit
$1B
Operating income
$554.1M
Net income
$467.2M
EBIT
$584.2M
EBITDA
$744M
Free cash flow
$306.9M
Per share
EPS
$6.42
EPS diluted
$6.37
Free cash flow per share
$4.23
Book value per share
$37.11
Revenue per share
$39.94
TBVPS
$48.29
Balance sheet
Total assets
$3.62B
Total liabilities
$935.1M
Debt
$303.2M
Equity
$2.68B
Working capital
$930.8M
Liquidity
Debt to equity
0.11
Current ratio
2.77
Quick ratio
1.8
Net debt/EBITDA
-0.14
Margins
EBITDA margin
25.7%
Gross margin
34.5%
Net margin
16.1%
Operating margin
19.1%
Efficiency
Return on assets
13%
Return on equity
17.5%
Return on invested capital
21%
Return on capital employed
18.9%
Return on sales
20.2%
Dividend
Dividend yield
0.38%
DPS
$0.83
Payout ratio
12.9%

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
2.83%
1 week
1.68%
1 month
3.59%
1 year
-38.82%
YTD
-33.86%
QTD
-3.23%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.9B
Gross profit
$1B
Operating income
$554.1M
Net income
$467.2M
Gross margin
34.5%
Net margin
16.1%
The net income has contracted by 18% YoY and by 5% from the previous quarter
WST's net margin is down by 17% year-on-year and by 5% since the previous quarter
WST's operating income is down by 14% YoY and by 2.8% from the previous quarter
The operating margin has declined by 13% year-on-year and by 3% since the previous quarter

Price vs fundamentals

How does WST's price correlate with its fundamentals

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
P/E
33.74
P/B
5.84
P/S
5.42
EV/EBIT
26.47
EV/EBITDA
20.78
EV/Sales
5.34
The stock's price to earnings (P/E) is 29% less than its 5-year quarterly average of 47.3 and 22% less than its last 4 quarters average of 43.5
WST's EPS is down by 16% year-on-year and by 4.9% since the previous quarter
The price to book (P/B) is 43% lower than the 5-year quarterly average of 10.2 and 27% lower than the last 4 quarters average of 8.0
The P/S is 40% below the 5-year quarterly average of 9.0 and 28% below the last 4 quarters average of 7.5

Efficiency

How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is down by 24% year-on-year and by 6% since the previous quarter
The company's return on assets fell by 15% YoY and by 5% QoQ
WST's return on sales is down by 14% year-on-year and by 2.9% since the previous quarter
West Pharmaceutical Services's ROE has decreased by 14% YoY and by 4.9% from the previous quarter

Dividends

What is WST's dividend history
DPS
$0.83
Dividend yield
0.38%
Payout ratio
12.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did West Pharmaceutical Services financials performed over time
West Pharmaceutical Services's current ratio has increased by 6% YoY
West Pharmaceutical Services's quick ratio has decreased by 4.3% from the previous quarter but it has increased by 3.4% YoY
WST's debt is 89% smaller than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.